Approximately 25% of the weight lost on tirzepatide was lean mass rather than fat, and in semaglutide trials (STEP 1 DXA subset), that proportion may approach 40%
In the context of BD, small-scale studies and case series have demonstrated that GLP-1 RAs such as liraglutide and semaglutide may mitigate antipsychotic-induced weight gain and metabolic dysregulation, particularly in PlwBD resistant to lifestyle interventions or metformin therapy (81, 82, 84, 85)
In summary, these data suggest one of neuroprotective effects of GLP-1R agonists is inhibiting neuronal apoptosis
Why GLP-1 Treatment for PCOS Requires a Specialist GLP-1 medications are often prescribed in a way that focuses only on obesity
This option is ideal for men seeking a guided, medically supervised approach to sustainable weight-management results
A.McCleanP